Skip to main content
SpringerLink
Log in

The role of dopamine in pilocarpine-induced catalepsy

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The cataleptic effect of the cholinomimetic compound, pilocarpine, was compared to the pilocarpine-induced changes in striatal dopamine metabolism in rats.

Pilocarpine induced catalepsy, the intensity of which increased with increasing dosage, but it did not make rats maximally cataleptic in the doses studied here. Doses higher than 200 mg/kg i.p. could not be studied because of toxicity. Pilocarpine increased the striatal homovanillic acid (HVA) content up to three times the original concentration. The greatest increase was found 2 h after 50 mg/kg of pilocarpine. Atropine (50 mg/kg) antagonized both the catalepsy and HVA increase produced by pilocarpine (200 mg/kg). Apomorphine (10 mg/kg) lowered the striatal HVA content by about 85%. This decrease had disappeared after 4 h. Apomorphine antagonized the HVA increase caused by 50 mg/kg of pilocarpine, but after an initial decrease apomorphine potentiated the HVA increase produced by 200 mg/kg of pilocarpine. Apomorphine did not modify the slight cataleptic effect of 50 mg/kg of pilocarpine but potentiated and prolonged the catalepsy produced by 200 mg/kg of pilocarpine. Pilocarpine-catalepsy was potentiated by α-methyl-p-tyrosine (αMPT 250 mg/kg) and pilocarpine accelerated the dopamine decrease caused by αMPT. Pilocarpine alone in doses up to 200 mg/kg did not statistically significantly change the brain dopamine concentration.

These results show that when the striatal cholinergic mechanisms are disturbed changes are induced in striatal dopamine metabolism. The striatal cholinergic and dopaminergic systems are antagonistic but the dopaminergic system can compensate for the overactivity of the striatal cholinergic system only to a certain extent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahtee, L., Kääriäinen, I., Paasonen, M. K.: Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus. Ann. Med. exp. Fenn. 50, 180–185 (1972)

    Google Scholar 

  • Andén, N.-E.: Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs. J. Pharm. Pharmacol. 24, 905–906 (1972)

    Google Scholar 

  • Andén, N.-E., Bédard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)

    Google Scholar 

  • Andén, N.-E., Roos, B. E., Werdinius, B.: On the occurence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. Life Sci. 2, 448–458 (1963)

    Google Scholar 

  • Arnfred, T., Randrup, A.: Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour. Acta pharmacol. (Kbh.) 26, 384–394 (1968)

    Google Scholar 

  • Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experientia (Basel) 27, 1302–1303 (1971)

    Google Scholar 

  • Corrodi, H., Fuxe, K., Hammer, W., Sjöqvist, F., Ungerstedt, U.: Oxotremorine and central monoamine neurons. Life Sci. 6, 2557–2566 (1967)

    Google Scholar 

  • Corrodi, H., Fuxe, K., Lidbrink, P.: Interaction between cholinergic and catecholaminergic neurones in rat brain. Brain Res. 43, 397–416 (1972)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forsch. 23, 674–683 (1973)

    Google Scholar 

  • Ernst, A. M.: The role of biogenic amines in the extra-pyramidal system. Acta physiol. pharmacol. neerl. 15, 141–154 (1969)

    Google Scholar 

  • Hornykiewicz, O.: Dopamine in the basal ganglia. Brit. med. Bull. 29, 172–178 (1973)

    Google Scholar 

  • Janssen, P. A. J.: Extrapolation from animals to man. In: Ciba Foundation Symposium, p. 439. Eds.: H. Steinberg, A. V. S. de Reuck, and J. Knight. London: Churchill 1964

    Google Scholar 

  • Keller, H. H., Bartholini, G., Pletscher, A.: Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression. J. Pharm. Pharmacol. 25, 433–436 (1973)

    Google Scholar 

  • Kruk, Z. L.: The effect of drugs acting on dopamine receptors on the body temperature of the rat. Life Sci. Part I 11, 845–850 (1972)

    Google Scholar 

  • Lahti, R. A., McAllister, B., Wozniak, J.: Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs. Life Sci. Part I, 11, 605–613 (1972)

    Google Scholar 

  • Laverty, R., Sharman, D. F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit. J. Pharmacol. 24, 759–772 (1965)

    Google Scholar 

  • O'Keeffe, R., Sharman, D. F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970)

    Google Scholar 

  • Papeschi, R., Randrup, A.: Catalepsy, sedation and hypothermia induced by α-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors. Pharmakopsychiat. Neuropsychopharmak. 6, 137–157 (1973)

    Google Scholar 

  • Portig, P. J., Sharman, D. F., Vogt, M.: Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus. J. Physiol. (Lond.) 194, 565–572 (1968)

    Google Scholar 

  • Roos, B. E.: Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J. Pharm. Pharmacol. 21, 263–264 (1969)

    Google Scholar 

  • Sasame, H. A., Perez-Cruet, J., Di Chiara, G., Tagliamonte, A., Tagliamonte, P., Gessa, G. L.: Evidence that methadone blocks dopamine receptors in the brain. J. Neurochem. 19, 1953–1957 (1972)

    Google Scholar 

  • Scheel-Krüger, J.: Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice. Acta pharmacol. (Kbh.) 28, 1–16 (1970)

    Google Scholar 

  • Shellenberger, M. K., Gordon, J. H.: A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine and 5-hydroxytryptamine from discrete brain areas. Analyt. Biochem. 39, 356–372 (1971)

    Google Scholar 

  • Simon, P., Malatray, J., Boissier, J. R.: Antagonism by amantadine of prochlorpemazine-induced catalepsy. J. Pharm. Pharmacol. 22, 546–547 (1970)

    Google Scholar 

  • Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965)

    Google Scholar 

  • Zetler, G.: Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. Int. J. Neuropharmacol. 7, 325–335 (1968)

    Google Scholar 

  • Zetler, G.: Anticataleptic actions of amantadine hydrochloride. Naunyn-Schmiedebergs Arch. Pharmak. 266, 276–278 (1970)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Helsinki, Siltavuorenpenger 10, SF-00170, Helsinki 17, Finland

    Liisa Ahtee & I. Kääriäinen

Authors
  1. Liisa Ahtee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Kääriäinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by the National Research Council for Medical Sciences Finland, and the Finnish Medical Society, Duodecim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahtee, L., Kääriäinen, I. The role of dopamine in pilocarpine-induced catalepsy. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 25–38 (1974). https://doi.org/10.1007/BF00499970

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00499970

Key words

Search

Navigation